Remodelling of nasal mucosa in mild and severe persistent allergic rhinitis with special reference to the distribution of collagen, proteoglycans, and lymphatic vessels

Clinical and Experimental Allergy

Volumn 40, Issue 12, 2010, Pages 1742-1754

  Kim, T H ^a   Lee, J Y ^b   Lee, H M ^a   Lee, S H ^a   Cho, W S ^c   Ju, Y H ^a   Park, E H ^a   Kim, K W ^a   Lee, Sang Hag ^a  

^a Korea University College of Medicine   (South Korea)

^b Soonchunhyang University   (South Korea)

^c Bundang Jesaeng Hospital   (South Korea)

Author keywords

Allergic nasal mucosa; Biglycan; Collagen; D2 40; Decorin; Lumican; Lymphangiogenesis; MMP; TIMP

Indexed keywords

BIGLYCAN; COLLAGEN; DECORIN; GELATINASE A; GELATINASE B; LUMICAN; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; MALE; NOSE MUCOSA; OPTICAL DENSITY; PERENNIAL RHINITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ADULT; BIGLYCAN; CHONDROITIN SULFATE PROTEOGLYCANS; COLLAGEN; DECORIN; HUMANS; KERATAN SULFATE; LYMPHATIC VESSELS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; NASAL MUCOSA; PROTEOGLYCANS; RHINITIS, ALLERGIC, PERENNIAL; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; YOUNG ADULT;

EID: 78349241719     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2010.03612.x     Document Type: Article

References (49)

1. Ciprandi G, Cirillo I, Klersy C, Marceglia GL, Caimmi D, Vizzaccaro A. Nasal obstruction is the key symptom in hay fever patients. Otolaryngol Head Neck Surg 2005; 133:429-35.
2. Ciprandi G, Pistorio A, Tosca M, Cirillo I. Relationship between rhinitis duration and response to nasal decongestion test. Laryngoscope 2008; 118:1139-41.
3. Ciprandi G, Klersy C, Ameli F, Cirillo I. Clinical assessment of a nasal decongestion test by visual analog scale in allergic rhinitis. Am J Rhinol 2008; 22:502-5.
4. Horak F, Stubner P, Zieglemayer R, Harris AG. Effect of desloratadine versus placebo on nasal airflow and subjective measure of nasal obstruction in subjects with grass pollen-induced allergic rhinitis in an allergen-exposure unit. J Allergy Clin Immunol 2002; 109:956-61.
5. Salib RJ, Howarth PH. Remodeling of the upper airways in allergic rhinitis: is it a feature of this disease? Clin Exp Allergy 2003; 33:1629-33.
6. Bousquet J, Jacquot W, Vignola AM, Bachert C, Van Cauwenberge P. Allergic rhinitis: a disease remodeling the upper airways? J Allergy Clin Immunol 2004; 113:43-9.
7. Ciprandi G, Cirillo I, Pistorio A, La Grutta S. Relationship between rhinitis duration and worsening of nasal function. Otolaryngol Head Neck Surg 2008; 138:726-9.
8. Bousquet J, Chanez P, Lacoste JY et al. Asthma: a disease remodeling the airways. Allergy 1992; 47:3-11.
9. Kresse H, Schonherr E. Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 2001; 189:266-74.
10. De Madeiros Matsushita M, Da Silva LF, Dos Santos MA et al. Airway proteoglycans are differentially altered in fatal asthma. J Pathol 2005; 207:102-10.
11. Pini L, Hamid Q, Shannon J et al. Differences in proteoglycan deposition in the airways of moderate and severe asthmatics. Eur Respir J 2007; 29:71-7.
12. Schaeffer L, Grone HJ, Raslik I et al. Small proteoglycans of normal adult human kidney: distinct expression patterns of decorin, biglycan, fibromodulin, and lumican. Kidney Int 2000; 58:1557-68.
13. Wen Y, Zhao YY, Li S, Polan ML, Chen BH. Differences in mRNA and protein expression of small proteoglycans in vaginal wall tissue from women with and without stress urinary incontinence. Hum Reprod 2007; 6:1718-24.
14. Nagase H, Ogata Y, Suzuki K, Enghild JJ, Salvesen G. Substrate specificities and activation mechanisms of matrix metalloproteinases. Biochem Soc Trans 1991; 19:715-8.
15. Stetler-Stevenson M, Mansoor A, Lim M et al. Expression of matrix metalloproteinases and tissue inhibitors of emtalloproteinases in reactive and neoplastic lymphoid cells. Blood 1997; 89:1708-15.
16. Wilson JW, Bamford TL. Assessing the evidence for remodeling of the airway in asthma. Pul Pharmacol Ther 2001; 14:229-47.
17. Klagsbrun M, D'Amore PA. Regulators of angiogenesis. Annu Rev Physiol 1991; 53:217-39.
18. Hoshino M, Nakamura Y, Hamid QA. Gene expression of vascular endothelial growth factor and its receptor and angiogenesis in bronchial asthma. J Allergy Clin Immunol 2001; 107:1034-8.
19. Mori S, Fujieda S, Sunaga H, Fox SB, Saito H. Expression of platelet-derived endothelial cell growth factor and vascularity in the nasal mucosa from allergic rhinitis. Clin Exp Allergy 2000; 30:1637-44.
20. Kirmaz C, Ozbilgin K, Yuksel H, Bayrak P, Unlu H, Giray G. Increased expression of angiogenic markers in patients with seasonal allergic rhinitis. Eur Cytokine Netw 2004; 15:317-22.
21. Ebina M. Remodeling of airway walls in fatal asthmatics decreases lymphatic distribution; beyond thickening of airway smooth muscle layers. Allergol Int 2008; 57:165-74.
22. Bousquet J, Van Cauwenberge P, Khaltaev NAria Workshop group; World H ealth O rganization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001; 108 (Suppl. 5):S147-334.
23. Ruifrok AC, Johnston DA. Quantification of histochemical staining by deconvolution. Anal Quant Cytol Histol 2001; 23:291-9.
24. Weidner N, Carroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol 1993; 143:401-9.
25. Sanai A, Nagata H, Konno A. Extensive interstitial deposition on the basement membrane zone in allergic nasal mucosa. Acta Otolaryngol (Stockholm) 1999; 119:473-8.
26. Nakaya M, Dohi M, Okunishi K et al. Prolonged allergen challenge in murine nasal allergic rhinitis: nasal airway remodeling and adaptation of nasal airway responsiveness. Laryngoscope 2007; 117:881-5.
27. Wilson JW, Li X. The measurement of reticular basement membrane and submucosal collagen in the asthmatic airways. Clin Exp Allergy 1997; 27:363-71.
28. Chakir J, Shannon J, Molet S et al. Airway remodeling-associated mediators in moderate to severe asthma: effects of steroids on TGF-beta, IL-11, IL-17, and type I and type III collagen expression. J Allergy Clin Immunol 2003; 111:1293-8.
29. Chu HW, Halliday JL, Martin RJ, Leung DYM, Szefler SJ, Wenzel SE. Collagen deposition in large airways may not differentiate severe asthma from milder forms of the disease. Am J Respir Crit Care Med 1998; 158:1936-44.
30. Dolhnikoff M, Da Silva LF, De Araujo BB et al. The outer wall of small airways is a major site of remodeling in fatal asthma. J Allergy Clin Immunol 2009; 123:1090-7.
31. Iozzo RV. Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 1998; 67:609-52.
32. Asakura S, Kato H, Fujino S, Konishi T, Tezuka N, Mori A. Role of transforming growth factor-β 1 and decorin in development of central fibrosis in pulmonary adenocarcinoma. Hum Pathol 1999; 30:195-8.
33. Venkatesan N, Roughley P, Ludwig MS. Proteoglycan expression in bleomycin lung fibroblasts: role of transforming growth factor-β1 and interferon-γ. Am J Physiol Lung Cell Mol Physiol 2002; 283:L806-14.
34. Vignola AM, Chanez P, Chiappara G et al. Transforming growth factor-β expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med 1997; 156:591-9.
35. Kahari VM, Larjava H, Uitto J. Differential regulation of extracellular matrix proteoglycan (PG) gene expression. Transforming growth factor-β1 up-regulates biglycan(PGI), and versican (large fibroblast PG) but down-regulates decorin (PGII) mRNA levels in human fibroblasts in culture. J Biol Chem 1991; 266:10608-15.
36. Salib RJ, Kumar S, Wilson SJ, Howarth PH. Nasal mucosal immunoexpression of the mast cell chemoattractants TGF-beta, eotaxins, and stem cell factor and their receptors in allergic rhinitis. J Allergy Clin Immunol 2004; 114:799-806.
37. Blochberger TC, Vergnes JP, Hempel J, Hassell JR. cDNA to chick lumican (corneal keratan sulphate proteolgycan) reveals homology to the small interstitial proteoglycan gene family and expression in muscle and intestine. J Biol Chem 1992; 267:347-52.
38. Grover J, Chen XN, Korenberg JR, Roughley PJ. The human lumican gene. Organization, chromosomal location and expression in articular cartilage. J Biol Chem 1995; 270:21942-9.
39. Nakamura K, Rockson S. Molecular targets for therapeutic lymphangiogenesis in lymphatic dysfunction and disease. Lymphat Res Biol 2008; 6:181-9.
40. Halin C, Detmar M. Chapter 1. Inflammation, angiogenesis, and lymphangiogenesis. Methods Enzymol 2008; 445:1-25.
41. Hildebrand A, Romaris M, Rasmussen LM et al. Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor β. Biochem J 1994; 302:527-34.
42. Wong DT et al. Eosinophils from patients with blood eosinophilia express transforming growth factor beta 1. Blood 1991; 78:2702-7.
43. Spinale FG. Myocardial matrix remodeling and the matrix mealloproteinases: influence on cardiac form and function. Physiol Rev 2007; 87:1285-342.
44. Shaida A, Kenyon G, Devalia J et al. Matrix metalloproteinases and their inhibitors in the nasal mucosa of patients with perennial allergic rhinitis. J Allergy Clin Immunol 2001; 108:791-6.
45. Kyo Y, Kanai K, Asano K, Hisamitsu T, Suzaki H. Suppressive effect of fluticasone propionate on MMP expression in the nasal mucosa of allergic rhinitis patients in vivo. In Vivo 2006; 20:439-44.
46. Araujo BB, Dolhnikoff M, Silva LEF, Elliot J et al. Extracellular matrix components and regulators in the airway smooth muscle in asthma. Eur J Respir 2008; 32:61-9.
47. Lim YS, Won TB, Shim WS et al. Induction of airway remodeling of nasal mucosa by repetitive allergen challenge in a murine model of allergic rhinitis. Ann Allergy Asthma Immunol 2007; 98:22-31.
48. Geng Y, McQuillan D, Roughley PJ. SLRP interaction can protect collagen fibrils from cleavage by collagenases. Matrix Biol 2006; 25:484-91.
49. Busti C, Falcinelli E, Momi S, Gresele P. Matrix metalloproteinases and peripheral arterial disease. Intern Emerg Med 2010; 5:13-25.